Lantus Cost in 2025: Availing Discounts and Additional Savings
Lantus, a long-acting insulin used for diabetes treatment, is available for adults and some children. However, the cost of Lantus can vary based on factors such as insurance coverage, treatment plan, and pharmacy.
Good news for those who may struggle with the cost of Lantus: there are alternatives available. Two biosimilar versions of Lantus, Semglee (insulin glargine-yfgn) and Rezvoglar (insulin glargine-aglr), have been approved by the FDA and are generally considered interchangeable with Lantus. These biosimilars, along with Basaglar (insulin glargine), offer a cost advantage over Lantus due to biosimilar competition, interchangeability status, payer policies, and generic-like substitution freedom [1][2][4].
Semglee and Rezvoglar, like Basaglar, are biologic drugs containing the active ingredient insulin glargine. They are designed to provide similar efficacy and safety as Lantus, but at a lower cost. In fact, goodRx offers ways to access these insulin formulations at discounted rates, sometimes as low as about $35 per month on savings programs, which is significantly cheaper than full brand prices [1][2].
It's important to note that while biosimilars like Semglee, Rezvoglar, and Basaglar offer cost savings, brand loyalty and extras bundled by Lantus, such as digital support and smart pen compatibility, can influence pricing dynamics [4]. Additionally, the cost of Lantus SoloStar pens and vials may differ due to insurance coverage and specific plan preferences; it's best to contact your insurance provider for more information.
For those without insurance, the Sanofi Insulins Valyou Savings Program is available, while the Sanofi US Copay Program is for people with commercial insurance, but not government-funded insurance like Medicare. If you have a prescription for Lantus and are interested in taking Rezvoglar, Semglee, or Basaglar instead, it's essential to consult your doctor.
Moreover, getting a 90-day supply of Lantus may reduce its cost if approved by your insurance company. Lantus may also be available through a mail-order pharmacy, which may help lower its cost. Websites like Medicine Assistance Tool and NeedyMeds provide details about drug assistance programs and savings cards that can help manage the cost of diabetes treatment.
In summary, Semglee, Rezvoglar, and Basaglar offer affordable alternatives to Lantus for diabetes treatment. By understanding the cost factors and consulting your healthcare provider, you can make informed decisions about your diabetes management.
- Health insurers and health-and-wellness deciders might find the cost of Lantus, a diabetes treatment drug, to be higher due to lack of biosimilar competition, while drugs like Semglee, Rezvoglar, and Basaglar, despite offering similar efficacy and safety, could present a cost advantage.
- Nutrition and health providers could recommend biosimilars such as Semglee or Rezvoglar for their patients struggling with the cost of Lantus, as they provide similar health benefits at lower prices.
- For those without health insurance, science-backed programs like the Sanofi Insulins Valyou Savings Program or the Sanofi US Copay Program might offer assistance in managing the cost of diabetes treatment, including Lantus and its biosimilars.
- By advocating for a 90-day supply of Lantus or obtaining the medication through a mail-order pharmacy, individuals could potentially lower the cost of their diabetes treatment, as indicated by various health-and-wellness resources like Medicine Assistance Tool and NeedyMeds.
